Immature B cells developing in the bone marrow are found in the parenchyma and sinusoids. The mechanisms that control the positioning of B cells in the sinusoids are not understood. Here we show that the integrin a 4 b 1 (VLA-4) and its ligand VCAM-1 were required, whereas the chemokine receptor CXCR4 was dispensable, for sinusoidal retention of B cells. Instead, cannabinoid receptor 2 (CB2), a Ga i protein-coupled receptor upregulated in immature B cells, was required for sinusoidal retention. Using two-photon microscopy, we found immature B cells entering and crawling in sinusoids; these immature B cells were displaced by CB2 antagonism. Moreover, CB2-deficient mice had a lower frequency of immunoglobulin k-chain-positive B cells in the peripheral blood and spleen. Our findings identify unique requirements for the retention of B cells in the bone marrow sinusoidal niche and suggest involvement of CB2 in the generation of the B cell repertoire.
The bone marrow contains specialized yet poorly defined microenvironments that help maintain stem cells and support hematopoiesis. In early studies examining the compartmentalization of developing B cells, B220 + cells and immature immunoglobulin M-positive (IgM + ) cells were found scattered throughout the bone marrow parenchyma, and immature IgM + cells have also been reported in sinusoids [1] [2] [3] [4] . Bone marrow sinusoids are specialized thin-walled venous blood vessels that travel through the tissue parenchyma, often joining by anastomosis before connecting to the large central sinusoid that carries the blood and newly produced cells to the venous circulation 5 . All cells produced in the bone marrow, including red blood cells, platelets, granulocytes and lymphocytes, are thought to enter the circulation through the sinusoids 5 . Given this cellular diversity, sinusoids are unexpectedly enriched for lymphocytes, and it has been suggested that there might be 'lymphocyte loading' of sinusoids 2, 6 . However, the mechanisms that control the retention of immature B cells in bone marrow sinusoids or their release from these sinusoids have not been defined.
The integrin-ligand pair a 4 b 1 (VLA-4)-VCAM-1 helps retain hematopoietic stem cells in the bone marrow [7] [8] [9] . VCAM-1 is expressed by a subset of bone marrow stromal cells and by sinusoidal endothelium 9 . The function of a 4 b 1 -VCAM-1 interactions in B cell development or retention in the bone marrow has been unclear, as some gene-ablation studies have suggested minimal involvement [10] [11] [12] [13] , whereas others have documented fewer immature and mature B cells in the bone marrow after ablation 14, 15 . SDF-1 (CXCL12), a chemokine that can activate a 4 b 1 (ref. 16) , is produced by bone marrow stromal cells and has also been detected on bone marrow endothelium [17] [18] [19] . The SDF-1 receptor CXCR4 helps retain hematopoietic progenitor cells and developing B cells in the bone marrow 20, 21 and promotes the homing of progenitor cells, plasma cells and T cells from blood to bone marrow 19, 22, 23 . However, CXCR4 is partially downregulated between the pre-B cell and immature B cell stages 16, 21, [24] [25] [26] , and it is unclear whether CXCR4 continues to function in immature B cells.
The Ga i protein-coupled cannabinoid receptor 2 (CB2) is abundantly expressed in mature B cells and is also present in myeloid cells, natural killer cells and various other cell types 27, 28 . The CB2 ligand 2-arachidonoylglycerol (2-AG) is generated from arachidonic acidcontaining phospholipids and has been detected in many tissues, including bone 28, 29 . Intake of cannabinoid receptor agonists has a variety of effects on the immune system, but the direct in vivo actions of such agonists on lymphoid cells remain poorly understood 30 .
Here we use an in vivo pulse-labeling procedure to distinguish cells in bone marrow sinusoids from those in the parenchyma and to establish that the retention of immature B cell in sinusoids is dependent on a 4 b 1 and VCAM-1. We found that CXCR4 was not critical for retention in sinusoids but that pertussis toxin-mediated inhibition of Ga i displaced sinusoidal cells. The expression and function of CB2 were upregulated in immature B cells, and intrinsic deficiency in CB2 prevented the accumulation of immature B cells in bone marrow sinusoids. Using two-photon microscopy, we found immature B cells entering and crawling in bone marrow sinusoids; these cells were displaced by CB2 antagonism. Finally, CB2 deficiency resulted in a lower percentage of peripheral B cells that expressed immunoglobulin l-chain. Our findings identify unique requirements for the retention of B cells in the bone marrow sinusoidal niche and suggest a function for CB2 in the formation of the B cell repertoire.
RESULTS

Labeling of cells in bone marrow sinusoids
To examine the distribution of IgM + B cells in bone marrow parenchyma and sinusoids, we stained bone marrow sections for endothelial and basement membrane markers. Antibodies to laminin, a protein abundant in basement membranes, were effective in labeling bone marrow vessels; we identified sinusoids among laminin-expressing vessels on the basis of their large lumens and thin walls ( Fig. 1a ). We detected IgM + B cells in the femur and tibia both in the parenchyma and inside sinusoids ( Fig. 1a) , consistent with published studies 1, 4 .
To facilitate the quantification and phenotyping of sinusoidal B cells, we developed an in vivo labeling procedure. Studies have shown that injected antibodies rapidly equilibrated throughout the bone marrow 1,4,5 , and we found that biotin-conjugated CD19-specific antibodies labeled all bone marrow B cells within a few minutes of injection ( Supplementary Fig. 1 online) . To test the possibility that larger protein complexes may have more limited access to the parenchyma, we treated mice for 2 min with antibody to CD19 (anti-CD19; approximately 150 kilodaltons) coupled to phycoerytrhin (PE; 240 kilodaltons). In this case, there was a bimodal staining pattern for immature IgM + IgDand IgM + IgD lo B cells and mature B cells; in contrast, pro-and pre-B cells were unlabeled ( Fig. 1b) . Among the IgM + immature B cells, the IgD lo subset was most enriched for cells labeled with anti-CD19-PE ( Fig. 1b) . Injection of PE-conjugated antibodies for longer periods (5-10 min) eventually stained all bone marrow cells targeted by the antibodies (Supplementary Fig. 1 ). When we analyzed immature B cells using a single gate (encompassing IgM + IgDand IgM + IgD lo cells; Supplementary  Fig. 1 ), we found that 25.4% ± 5.9% (± s.d.; n ¼ 18 mice) were labeled with anti-CD19-PE. The extent of staining on the brightly labeled bone marrow B cell subsets approached the labeling intensity of cells from blood of the same mice ( Fig. 1c ). Immunofluorescence analysis of bone marrow sections from mice treated with anti-CD19-PE, after staining with anti-laminin, showed that the cells labeled with anti-CD19-PE were in sinusoids ( Fig. 1d and Supplementary Fig. 2 online). However, in vitro staining with anti-CD19-PE showed the expected distribution of CD19 + cells in both the parenchyma and sinusoids ( Fig. 1d and Supplementary Fig. 2 ). In some cases, the in vivo-labeled cells were located in regions of sinusoids adjoining the central collecting sinusoid ( Supplementary Fig. 2 ).
Using injection of anti-CD45-PE as an approach for labeling all hematopoietic cell types present in sinusoids, we found that cells of the B lineage constituted approximately two thirds of all sinusoidal cells and the remaining cells were mostly of the myeloid lineage (CD11b + , CD11c + and/or Gr-1 + ), together with smaller numbers of natural killer cells (NK1.1 + ) and CD4 + and CD8 + T cells (Fig. 1e) . The proportion of immature B cells labeled after injection of anti-CD45-PE was similar to that in mice treated with anti-CD19-PE (data not shown). Consistent with the flow cytometry data, analysis of bone marrow sections from mice treated with anti-CD19-PE and stained in vitro with anti-CD45 showed that B cells were the predominant CD45 + cell type in the sinsuoids (Fig. 1f ). In summary, treatment with PE-conjugated antibodies for 2 min in vivo allowed the selective labeling of cells present in bone marrow sinusoids, and this approach showed that about one quarter of immature B cells in the bone marrow are located in this bone marrow niche.
Retention of sinusoidal B cells by a4b1 and VCAM-1
To assess whether a 4 b 1 and VCAM-1 are involved in retaining immature B cells in bone marrow sinusoids, we treated mice for 3 h with blocking antibodies to a 4 or VCAM-1 or with saline and injected anti-CD19-PE 2 min before isolating tissues. We treated a separate group of mice with anti-a L to block the integrin a L b 2 (LFA-1). By counting parenchymal (anti-CD19-PE -) B lineage cells, we found that mice treated with a 4 -blocking antibodies had slightly but significantly fewer immature IgDand IgD lo cells, whereas in mice treated with anti-a L , the numbers remained unchanged ( Fig. 2a ). The number of mature B cells was also diminished by treatment with anti-a 4 and anti-VCAM-1 but not by treatment with anti-a L (Fig. 2a) . In contrast to those mild effects, we found a considerably fewer immature B cells inside the sinusoids (anti-CD19-PE + ) of mice treated with a 4 -or VCAM-1-blocking antibodies ( Fig. 2b ). There were also fewer sinusoidal mature B cells. However, treatment with anti-a L did not result in significant changes in the number of sinusoidal B cells ( Fig. 2b) . By counting IgM + cells in frozen sections, we confirmed the displacement of B cells from bone marrow sinusoids after a 4 blockade (Supplementary Fig. 3 online). Release of cells from bone marrow sinusoids of mice treated with a 4 -or VCAM-1-blocking antibodies was reflected in a significant increase in the numbers of the same B cell subsets in the peripheral blood (P o 0.005; Supplementary Fig. 3 ). We also detected some pro-and pre-B cells in the blood, which often seemed prominent relative their absence in control blood; however, consistent with the bone marrow data, their absolute numbers were at least an order of magnitude lower than the number of immature B cells. Blocking P-selectin or blocking P-and E-selectins for 3 h did not result in significant changes in the number of B cells in bone marrow sinusoids (data not shown).
We were able to distinguish immature B cells in the bone marrow parenchyma and sinusoids from those in the blood by their higher cell surface expression of CD93 (AA4.1; Fig. 2c ). Notably, the immature B cells found in blood after treatment with anti-a 4 resembled those in the bone marrow in terms of CD93 expression ( Fig. 2c ). This finding is consistent with the conclusion that the increase in blood immature B cells was due to release of cells from the bone marrow. The CD93 staining data also emphasized the phenotypic similarity of the bone marrow parenchymal and sinusoidal immature B cell populations ( Supplementary Fig. 1 ).
To assess the function of the b 1 integrin chain in the retention of B cells in sinusoids, we crossed mice bearing loxP sites flanking Itgb1 (which encodes b 1 integrin; Itgb1 f/f or Itgb1 f/+ mice) 31 with mice that express Cre recombinase from the Cd19 locus (Cd19 Cre/+ mice) 32 . In Itgb1 f/f Cd19 Cre/+ mice, the proportion of B cells that underwent deletion of Igtb1 (identified by lack of surface b 1 staining) increased gradually during B cell development ( Fig. 3a) , consistent with ongoing Cre-mediated deletion 33 . Pulse labeling with anti-CD45-PE showed that in Itgb1 f/+ Cd19 Cre/+ and Itgb1 f/f Cd19 Cre/+ mice, there was a strong 'bias' against b 1 -deficient immature B cells in the sinusoidal CD45 + compartment ( Fig. 3a,b ). In contrast, peripheral blood was enriched for immature B cells that had lost b 1 expression ( Fig. 3c) , consistent with the idea that b 1 promotes retention of these cells in the bone marrow. Analysis of mature B cells was difficult because surface staining of b 1 on this subset did not allow clear distinction between cells expressing and lacking b 1 (data not shown). These findings collectively indicate that a 4 b 1 and VCAM-1 are required for the retention of immature B cells and mature recirculating B cells in bone marrow sinusoids.
Retention in the parenchyma requires CXCR4
Cxcr4 transcripts were abundant in pre-B cells and were about 75% less abundant in immature IgDand IgD lo cells (Fig. 4a ). Using the Cd19-Cre system to ablate Cxcr4 in developing B cells, we found that a larger fraction of CXCR4-deficient immature bone marrow B cells, and nearly all CXCR4-deficient mature bone marrow B cells, were located inside sinusoids (Fig. 4b,c ). Cells that had not yet undergone Cre-mediated loss of Cxcr4 expression remained normally partitioned between parenchyma and sinusoids (Fig. 4b,c ), which established that the effect of Cxcr4 ablation was cell intrinsic. The incomplete Cxcr4 ablation in Cxcr4 f/f Cd19 Cre/+ mice made it difficult to determine the effect on total bone marrow cell numbers, but there was a trend toward fewer immature IgD lo B cells and significantly fewer mature B cells ( Fig. 4c ). When we globally inhibited CXCR4 in wild-type mice by 2 h of treatment with the CXCR4 antagonist 4F-benzoyl-TN14003 (ref. 34) , we found that the frequency and number of immature IgD lo and mature B cells were significantly lower in the bone marrow parenchyma and higher in the sinusoids (Fig. 4d) . The cells that accumulated in the sinusoids after treatment with 4F-benzoyl-TN14003, however, were released by blockade of a 4 integrin, leading to their greater representation in peripheral blood (Fig. 4e) . These findings suggest that immature B cells, especially the IgD lo subset, are retained in the bone marrow parenchyma in a CXCR4-dependent way, but that alternative retention mechanisms operate to promote integrin-mediated retention in bone marrow sinusoids.
As integrin activity in lymphoid cells is typically induced by Ga i -coupled receptors, we tested the effect of inhibiting all Ga i function with pertussis toxin. In mice treated for 1 d with pertussis toxin, there was considerable displacement of immature IgM + IgD lo B cells from bone marrow sinusoids ( Fig. 4f) . These observations suggested the involvement of additional Ga i -coupled receptors in promoting the retention of immature B cells in the sinusoidal niche.
CB2 retains immature B cells in sinusoids
A comparison of G protein-coupled receptor transcript abundance in pre-B cells and immature B cells with Affymetrix gene array data (accession code, GDS52) 35 showed higher expression of Cnr2 mRNA transcripts, which encode CB2, in immature B cells; we confirmed an increase of twofold by quantitative RT-PCR ( Fig. 5a) . In migration assays, immature B cells responded more strongly to the CB2 ligand 2-AG than did pro-or pre-B cells (data not shown), and among the immature cells, the response was greatest for the sinusoidal subpopulation ( Fig. 5b) . CB2-deficient mice had normal numbers of developing bone marrow B cells but had a dearth of immature B cells in sinusoids ( Fig. 5c ). However, CB2-deficient cells were over-represented among immature B cells in blood ( Fig. 5c) , consistent with defective retention in sinusoids. The total number of mature follicular B cells in blood ( Fig. 5c ) and spleen (data not shown) was not affected by CB2 deficiency. Analysis of mixed-bone marrow chimeras showed that the requirement for CB2 in the sinusoidal localization of immature (and mature) bone marrow B cells was cell intrinsic (Fig. 5d ). By mass-spectrometry analysis, we detected small amounts of the CB2 ligand 2-AG in plasma and large amounts of 2-AG in bone marrow, as well as in the spleen and brain (Fig. 5e ). Finally, transfer of activated B cells transduced with a retrovirus encoding CB2 showed that higher expression of CB2 resulted in more sinusoidal than parenchymal lodgment of transferred cells (Fig. 5f) . These findings demonstrate that CB2 has high activity in sinusoidal B cells and is required for their efficient lodgment in bone marrow sinusoids. 
Dynamic activity of sinusoidal B cells
To examine the migration dynamics of immature B cells in sinusoids, we did intravital two-photon microscopy of Rag1 GFP/+ cells in bone marrow in the mouse calvarium. Rag1 GFP/+ mice have a cassette encoding green fluorescent protein (GFP) 'knocked into' one allele encoding recombination-activating gene 1 (Rag1). As expected, using flow cytometry, we detected GFP in Rag1 GFP/+ pro-B cells and more abundant GFP in pre-B cells and immature B cells, whereas most mature B cells did not express GFP 36 (Fig. 6a) . Using in vivo CD19-PE labeling, we confirmed that the immature IgM + IgDand IgM + IgD lo B cells inside the sinusoids were GFP hi (Fig. 6a) and, reciprocally, that over 94% of the GFP hi sinusoidal B cells expressed CD93 (Fig. 6b) .
Using dextran-rhodamine to distinguish sinusoids and other blood vessels from bone marrow parenchyma, we identified many GFP + cells in the parenchyma, which most likely corresponded to pre-B cells and immature B cells; a fraction of these cells were motile ( Fig. 6c and Supplementary Movies 1 and 2 online) , some with median velocities of 4-7 mm/min (Fig. 6d) . Many of the cells with median velocities of 2-4 mm/min corresponded to cells that extended processes but showed little displacement above background movement in the tissue. Notably, there were also GFP + cells in vessels, and although many were poorly motile, some migrated in various directions ( Fig. 6e and Supplementary Movies 1 and 2) at median velocities ranging from 5 mm/min to 10 mm/min (Fig. 6d) . Although only small numbers of newly generated B cells are expected to migrate from the parenchyma into the sinusoids during imaging periods of 30-60 min, we did find several examples of GFP + cells entering sinusoids ( Fig. 6e and Supplementary Movie 1) . Notably, after entering, these cells remained adherent and in some cases continued to migrate. Occasionally, a cell in flow in the sinusoid became adherent and began crawling ( Fig. 6f and Supplementary Movie 2) . We also detected GFP + cells detaching and being rapidly carried away with the blood flow ( Supplementary Movie 2) . GFPcells appeared as dark halos in the dextran-rhodamine-labeled sinusoids and often moved bidirectionally in a given vessel (Supplementary Movies 1 and 2). Consistent with the fact that most immature sinusoidal B cells had recently entered from the bone marrow parenchyma, labeling experiments with the thymidine analog BrdU showed that sinusoidal B cells were replaced by newly generated cells with only a slight lag compared with the replacement of parenchymal B cells and more rapidly than immature B cells in the blood ( Supplementary Fig. 4 online) .
To further characterize how CB2 promotes cell lodgment in the sinusoids, we sought to determine whether cells were continuously dependent on CB2 signaling by testing the effect of treatment with SR144528, a CB2 antagonist 37 . We fount that 3 h of treatment with SR144528 led to considerable displacement of sinusoidal B cells and had no effect on parenchymal cells (Fig. 7a) . Immature B cell numbers were correspondingly greater in the blood of treated mice (Fig. 7a) . Intravital imaging at 90-240 min after SR144528 treatment showed more flowing GFP + cells than in the period before antagonist treatment (Fig. 7b) . Reciprocally, in an in vitro assay, incubation of bone marrow cells with 2-AG increased the adhesion of sinusoidal B cells to a VCAM-1-coated surface under shear flow (Fig. 7c) . These results collectively suggest that CB2 promotes the adhesion of immature B cells in bone marrow sinusoids.
Lower k+ B cell frequency
To assess the influence of CB2 on the development of the B cell repertoire, we examined the frequency of B cells positive for immunoglobulin k-chain (k + ) or immunoglobulin l-chain (l + ) in CB2deficient mice. CB2 deficiency led to a lower frequency of l + immature and mature B cells in the blood and spleen (Fig. 8a) . We obtained similar findings with mixed-bone marrow chimeras (Fig. 8b) . Treatment of wild-type mice with the CB2 antagonist for 6-9 d also led to a lower frequency of l + B cells among immature splenic B cells (Fig. 8c) . These observations provide evidence of a B cell-intrinsic function for CB2 in establishing the peripheral B cell repertoire. 
DISCUSSION
In the work presented here, we have demonstrated that approximately one quarter of the immature B cells in mouse bone marrow were situated inside the sinusoids. The cells migrated within this compartment, and their retention was dependent on a 4 b 1 -VCAM-1 interactions and on the Ga i -coupled receptor CB2. The presence of large numbers of adherent and migrating immature B cells in the sinusoids suggested that rather than serving solely to support blood flow, these vessels constitute a specialized cellular niche in the bone marrow that may influence B cell development. In support of the idea of such a function, CB2 deficiency led to a lower frequency of l + immature and mature B cells in the periphery. CB2 is abundantly expressed in B lymphocytes, and in vitro studies have described the migration of peripheral B cells in response to 2-AG 38, 39 . The number of marginal zone B cells is lower in the absence of CB2, although whether CB2 acts to promote the development, retention or survival of marginal zone B cells remains unclear 40 . Our studies suggest that CB2 promotes the a 4 b 1 -mediated adhesion of B cells to sinusoidal endothelial cells. In addition to Ga i signaling 16 , exposure to conditions of shear flow promotes the adhesive function of integrins 41 . Thus, CB2 signaling and shear may work together to promote a 4 b 1 -VCAM-1-mediated adhesion in bone marrow sinusoids. Although we believe this is the most parsimonious interpretation of our data, we cannot exclude the possibility that the in vivo actions of a4b1 and CB2 are independent and that CB2 acts by some other mechanism to promote cell positioning in sinusoids. Many cell types can make 2-AG 28 , although given the many 2-AGbiosynthetic pathways, new tools and approaches will be needed to determine whether endothelial cells or other bone marrow cell types are the relevant source of this lipid. It is notable that immature B cells from sinusoids were more responsive to 2-AG than were parenchymal cells, which suggests that a change in CB2 receptor function occurs as immature B cells enter, or commit to entering, the vascular compartment.
The development of l + B cells is delayed by several hours compared with that of k + cells, and many l + cells show evidence of receptor editing at the Igk locus 42, 43 . Studies of immunoglobulin-transgenic systems have shown that the frequency of l + B cells correlates with the extent of receptor editing 44 . We speculate that by diminishing the total time cells spend in the bone marrow, CB2 deficiency might diminish the time available for receptor editing and thus the frequency of l + B cells. The lower frequency of l + B cells among immature blood and splenic B cells at first seemed consistent with such a scenario. However, our inability to detect a lower frequency of l + B cells in the bone marrow suggests that CB2 deficiency affects processes acting after l-chain rearrangement. We propose that the lower retention time for immature B cells in sinusoids increases the likelihood of loss of l + B cells during or shortly after their release into the periphery. It is notable that there was a lower frequency of l + B cells in the mature than in the immature splenic B cell compartment of wild-type mice, which suggests that l + cells are prone to negative selection after release from the bone marrow. CB2 deficiency and disrupted occupancy of the bone marrow sinusoidal niche may exaggerate this effect. It is possible that CB2 deficiency also causes loss of B cells bearing certain Igk rearrangements, and it will be valuable to analyze the diversity of the k-chain repertoire in future studies. Although our data are consistent with the possibility that the altered peripheral B cell repertoire is a consequence of the sinusoidal CB2 function, we cannot exclude the possibility that it is also due to a peripheral function of this receptor. Treatment with agonists of cannabinoid receptors can lead to alterations in antibody responses 30, 45, 46 .
The function of CB2 in the formation of the B cell repertoire may contribute to those altered responses.
Published work has suggested a lack of effect on B cell development in adult mice in which integrin a 4 or integrin b 1 is conditionally ablated [10] [11] [12] , whereas other reports have shown a selective decrease in immature B cell numbers in the bone marrow after conditional VCAM-1 ablation 14, 15 . Our findings are in agreement with the latter studies and further indicate that the cells most dependent on a 4 b 1 -VCAM-1-mediated adhesion are cells located in bone marrow sinusoids. Moreover, we have provided evidence that the adhesive activity of a 4 b 1 may be promoted by ligand engagement of CB2.
By intravital imaging, we found that the parenchymal Rag1expressing B cell population was made up both of sessile and migratory cells. Examination of cell distribution in static images of bone marrow showed that repositioning occurred between the pro-B cell and pre-B cell stages 47 , which means it is likely that some of the migrating parenchymal cells are pre-B cells. We speculate that many immature B cells are also motile, perhaps surveying for autoantigens or sites of entry to sinusoids. Studies of transferred cells have shown that mature B cells are able to migrate in the bone marrow parenchyma, although the fraction of cells migrating and the migration velocities were not determined in those studies 48 . In the sinusoids, the Rag1-GFP label was specific for immature B cells, which allowed us to conclude that sinusoidal immature B cells include both actively migrating and poorly motile cells. The purpose of the B cell motility is not yet clear, but it may facilitate encounter with sinusoidal self antigens. Our detection of immature B cells entering and then crawling in bone marrow sinusoids establishes the idea that at least some of the sinusoidal B cells are cells that recently entered the structures. Our data indicate that immature B cells may also sometimes transition from a flowing, nonadherent state to an adherent state. Video microscopy of sinusoids in rabbit tibia has shown alternating movement and stagnation in the blood flow 5 . Irregularly shaped sinusoids with unpredictable fluctuations in blood flow have also been reported in published studies of mouse frontoparietal skull bone marrow 8 . It seems likely that given such unusual blood flow characteristics, cells that detach may frequently re-encounter the sinusoidal wall rather than being immediately flushed from the marrow, providing additional opportunities for a 4 b 1 -VCAM-1-and CB2-mediated retention.
CXCR4 and SDF-1 serve many functions in the bone marrow, including the induction of cell adhesion to blood vessels 18, 23 . It was therefore unexpected that CXCR4 antagonism failed to displace immature B cells from sinusoids. That finding might be considered consistent with evidence from static adhesion assays showing that CXCR4 is ineffective in promoting sustained adhesion of immature B cells 16 . In contrast, the quantitatively greater release of IgM + IgD lo immature (and mature) B cells than of pro-or pre-B cells from the bone marrow parenchyma after CXCR4 blockade suggests that immature B cells are particularly dependent on CXCR4 for retention in the parenchyma. We propose that pro-and pre-B cells have additional retention systems that keep them in the bone marrow parenchyma. Reciprocally, immature B cells may have higher expression of receptors that respond to egress-promoting cues or molecules that facilitate motility and transendothelial migration. Despite the importance of CB2 in promoting the retention of immature B cells in bone marrow sinusoids, we did not detect accumulation of immature B cells in the parenchyma of CB2-deficient mice, which challenges the idea of an essential function for this receptor in promoting sinusoid entry, although a redundant contribution of CB2 to this step is not excluded.
Intravascular lymphoma is a condition in which malignant B cells accumulate inside blood vessels, sometimes including bone marrow sinusoids 49 . The bone marrow is also a site of tumor metastasis, and SDF-1 has been linked to promotion of the adhesion of malignant cells in bone marrow blood vessels 18 . Further studies are needed to determine if CB2 and 2-AG also promote the adhesion of lymphoma and tumor cells in bone marrow sinusoids.
METHODS
Mice. Adult C57BL/6 (Ly5.2 + ) mice 6-8 weeks of age were from The Jackson Laboratories or the National Cancer Institute, and adult Boy/J (Ly5.1 + ; 002014) mice were from The Jackson Laboratories. Cnr2 -/mice (005786; The Jackson Laboratories) were backcrossed to C57BL/6 mice for seven to ten generations. Cxcr4 +/mice 50 were crossed to Cxcr4 f/f mice 21 and to Cd19 Cre/+ mice 32 to generate Cxcr4 f/-Cd19 Cre/+ and control littermates. Itgb1 f/f mice 31 (004605; The Jackson Laboratories) were crossed to Cd19 Cre/+ mice to generate Itgb1 f/f mice expressing a single Cd19 Cre allele or were further intercrossed to obtain Itgb1 f/f mice expressing two Cd19 Cre alleles and control littermates. Rag1 GFP/+ mice 36 were provided by T. Gerdes and M. Wabl. For the generation of bone marrow chimeras, approximately 1.5 Â 10 6 total bone marrow cells from either Cnr2 +/+ or Cnr2 -/-(Ly5.2 + ) mice were mixed with 1.5 Â 10 6 total bone marrow cells from adult Boy/J (Ly5.1 + ) mice and were transferred into adult Boy/J mice that had been exposed to two rounds of 550 rads separated by 3 h. Chimeras were analyzed at least 6 weeks after reconstitution. Intravital two-photon microscopy and labeling with BrdU (5-bromodeoxyuridine) are described in the Supplementary Methods online.
Labeling of sinusoidal cell populations. Sinusoidal cells were labeled by injection of mice intravenously for 2 min with 1 mg phycoerythrin-conjugated rat anti-mouse CD19 (1D3; BD Biosciences) or mouse anti-mouse CD45.2 (Ly5.2-PE; 104; BD Biosciences) in 200 ml PBS (unless otherwise indicated). Mice were then immediately killed in a CO 2 chamber and tissues were prepared as described 22 . In some experiments, mice were injected with various doses of biotin-conjugated rat anti-mouse CD19 (1D3; BD Biosciences). Bone marrow cells from mutant and control mice were then stained with fluorescein isothiocyanate-conjugated anti-IgD (26C.2A; BD Biosciences), phycoerythrinindotricarbocyanine-conjugated anti-IgM (II/41; eBioscience), phycoerythrincyanine 5.5-conjugated anti-CD19 (RM7718; Invitrogen), allophycocyaninconjugated anti-CD93 (AA4.1; eBioscience) and biotinylated anti-CXCR4 (2B11; BD) or unconjugated anti-b 1 integrin (MB1.2; Chemicon International) and biotin-SP-AffiniPure F(ab¢) 2 fragment goat anti-rat IgG, Fcg fragment specific (Jackson Immunoresearch), followed by streptavidin QD605 (Molecular Probes). In vivo integrin-, VCAM-1-, selectin-, CXCR4-and CB2-blocking protocols, as well as the description of cell sorting and chemotaxis and adhesion assays, are in the Supplementary Methods.
Histology. Femurs and tibias were placed in Tissue Tek optimum cutting temperature compound (Sakura) and were immediately frozen with a mixture of ethanol and dry ice and stored at -80 1C. Cryostat sections 7 mm in thickness were transferred to CJ1X adhesive-coated slides with the Cryojane Tape-Transfer system according to the manufacturer's protocol (Instrumedics). Slides were fixed in acetone and were incubated with incubated with rabbit anti-mouse laminin (L9393; Sigma) and rat anti-mouse IgD (biotinylated; 11-28; Southern Biotechnology), followed by horseradish peroxidase-conjugated goat anti-rabbit IgG (711-035-1520) and alkaline phosphatase-conjugated goat anti-rat IgG (712-055-150; both from Jackson ImmunoResearch), then slides were developed and mounted and images were collected as described 22 . For immunofluorescence, unfixed anti-laminin-stained slides were incubated with 7-amino-4methylcoumarin-3-acetic acid-conjugated goat anti-rabbit IgG (112-155-0030; Jackson Immunoresearch) and were analyzed with an inverted fluorescence imaging microscope (Axiovert 200M; Carl Zeiss MicroImaging) with a Plan-Neofluar 40 Â oil-immersion objective (numerical aperture, 1.3; Carl Zeiss MicroImaging). Images were captured with a charge-coupled device SensiCam (PCD; Cooke) and were analyzed with SlideBook software (Intelligent Imaging).
Mass spectrometry. A Micromass Quattro Ultima liquid chromatographytandem mass spectrometry system with an electrospray-positive ionization mode was used for analysis of 2-AG. The multiple-reaction monitor was set at 379.2 4 287.2 m/z for 2-AG and 387.4 4 294.5 m/z for the internal standard 2-AG-d8, which contains eight deuterium atoms (Cayman Chemicals) as internal standard. The cone voltage and collision energy were set at 35 V and 16 eV, respectively. The column was a Synergi Polar RP (75 mm Â 4.6 mm; 4-mm particle size) with a mobile phase consisting of 68% (vol/vol) acetonitrile containing 0.1% (vol/vol) formic acid. The flow rate was 1.0 ml/min with 1/4 split into the mass system.
Note: Supplementary information is available on the Nature Immunology website.
